Assignee
BATU BIOLOGICS INC
US·0 granted patents·33 pending applications·0 citations·filing 2016–2019
Top patents by PatentIndex Score
33 records- 0163US2017151281A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 0257US2019167720A1Gene editing for immunological destruction of neoplasiaBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 0351US2016228547A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 0450US2020297829A1Integrative Immunotherapy for Cancer TreatmentBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 0550US2018008670A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 0649US2017020922A1Gene editing for immunological destruction of neoplasiaBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 0749US2019224292A1Methods of Augmenting Tumor Vaccine Efficacy through Endothelial TargetingBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 0849US2019201511A1Placental Based Contraceptive VaccineBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 0949US2019255127A1Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial CellsBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1046US2019161798A1Selection of Donors for Generation of Anti-Angiogenic Vaccine Compositions Including ValloVaxBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 1146US2018264096A1Prophylactic Vaccine to Tumor AngiogenesisBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 1244US2018280444A1Nanoparticle based tumor endothelial targeting vaccineBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1344US2019239937A1Augmentation of Abscopal Effect of Cryotherapy and other Tumor Cell Death by Anti-angiogenic and Anti-tumor VaccinationBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1444US2017348388A1Adjuvants useful for stimulation of immunity to tumor endothelial cellsBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1544US2017348361A1Probiotic augmentation of anti-tumor endothelium immune responsesBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1643US2019117703A1Immunological treatment of liver failureBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 1743US2017216354A1Clinically useful non-antigen pulsed dendritic cellsBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1843US2018110847A1Immunotherapy of Cancer by Induction of Immunologically-Mediated Selective Killing of Tumor Vasculature Using Modified Endothelial Cells and Progenitors ThereofBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1943US2019282641A1Generation of Tumor Endothelium Specific VirusesBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 2042US2017100468A1Amplification of epitope specific personalized anti-angiogenic immune responsesBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2141US2018264049A1Immunotherapy of Aberrant Ocular Angiogenesis by Placental VaccinationBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 2241US2017165332A1Gene edited antigen presenting cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2340US2017196951A1Polyvalent anti-tumor fibroblast vaccineBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2440US2017128555A9Placental compositions for stimulation of immunity to pd-l1BATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2540US2017152506A1Inactivation of lymphocyte immunological checkpoints by gene editingBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2640US2017107510A1Dna nanoparticle based checkpoint inhibitorsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2739US2017100438A1Treatment of glioma by anti-angiogenic active immunization for direct tumor inhibition and augmentation of chemotherapy, immunotherapy and radiotherapy efficacyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2839US2016237407A1Universal donor chimeric antigen receptor cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2939US2016213764A1Composite tissue cancer vaccineBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3038US2017021002A1Augmentation of cancer and cancer endothelial vaccine immunogenicity by histone deacetylase inhibitorsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3137US2017095545A1Inhibition of tumor angiogenesis by checkpoint inhibitors and active vaccinationBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3237US2016231323A1Protection of tcr signaling chains in cancer patients and enhancement of car-t cell therapyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3335US2016340650A1Blood derived immune stimulatory compositionsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BATU BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →